Apolipoproteins C-III and A-V as Predictors of Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B-100 Kinetics
- 1 March 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 26 (3), 590-596
- https://doi.org/10.1161/01.atv.0000203519.25116.54
Abstract
Objective— We investigated the associations between plasma very-low-density lipoprotein (VLDL)–apolipoprotein (apo)C-III and apoA-V concentrations and the kinetics of VLDL–apoB-100 and VLDL triglycerides in 15 men. We also explored the relationship between these parameters of VLDL metabolism and VLDL–apoC-III kinetics. Methods and Results— ApoC-III, apoB, and triglyceride kinetics in VLDL were determined using stable isotopes and multicompartmental modeling to estimate production rate (PR) and fractional catabolic rate (FCR). Plasma VLDL–apoC-III concentration was significantly and inversely associated with the FCRs of VLDL triglycerides ( r =−0.610) and VLDL–apoB ( r =−0.791), and positively correlated with the PR of VLDL–apoC-III ( r =0.842). However, apoA-V concentration was not significantly associated with any of the kinetic variables. There was a significant association ( P r =0.641), and between the FCRs of VLDL triglycerides and VLDL–apoB ( r =0.737). In multiple regression analysis, plasma VLDL–apoC-III concentration was a significant predictor of VLDL triglyceride FCR (β-coefficient=−0.575) and VLDL–apoB FCR (β-coefficient=−0.839). Conclusions— Our findings suggest that increased VLDL–apoC-III concentrations resulting from an overproduction of VLDL–apoC-III are strongly associated with the delayed catabolism of triglycerides and apoB in VLDL. We also demonstrated that the kinetics of VLDL triglycerides and apoB are closely coupled. Our data do not support a role for plasma apoA-V in regulating VLDL kinetics.Keywords
This publication has 28 references indexed in Scilit:
- Postprandial increase of plasma apoAV concentrations in Type 2 diabetic patientsAtherosclerosis, 2005
- Overproduction of VLDL 1 Driven by Hyperglycemia Is a Dominant Feature of Diabetic DyslipidemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Apolipoprotein AV Accelerates Plasma Hydrolysis of Triglyceriderich Lipoproteins by Interaction with Proteoglycan-bound Lipoprotein LipaseJournal of Biological Chemistry, 2005
- ApoA-VArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemiaAtherosclerosis, 2004
- Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methodsClinical Science, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Transcriptional Regulation of Apolipoprotein C-III Gene Expression by the Orphan Nuclear Receptor RORαJournal of Biological Chemistry, 2001
- Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesityInternational Journal of Obesity, 1998
- Triglyceride-rich lipoproteins and the progression of coronary artery diseaseCurrent Opinion in Lipidology, 1995